In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.

Slides:

Advertisements

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Manuel J. Antunes, MD, PhD, DSc

Clinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years John B. Chambers, MD, FRCP,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study Vincent Chan,

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

Safety and efficacy of a novel temporary sternal spreader in the management of severe postcardiotomy cardiogenic shock: A preliminary report study Francesco.

Sergey Leontyev, MD, Michael A

Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation

Mitral mechanical replacement in young rheumatic women: Analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year.

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Aortic root remodeling leads to good valve stability in acute aortic dissection and preexistent root dilatation Takashi Kunihara, MD, PhD, Niklas Neumann,

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Surgery for acute type A aortic dissection on oral anticoagulants: Being the dispatcher of a 911 call Ourania Preventza, MD, Arthur Bracey, MD The Journal.

Form ever follows function

Reoperative “valve-in-valve” transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic.

William M. DeCampli, MD, PhD

Supracoronary ascending aortic replacement in patients with acute aortic dissection type A: What happens to the aortic root in the long run? Bartosz.

Bicuspid aortic valve aortopathy: One size fits all?

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery Pedro J.

The variability of the mitral valve anatomy and terminology

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

How should I wean my next intra-aortic balloon pump

Structural deterioration of the Freestyle aortic valve: Mode of presentation and mechanisms Siamak Mohammadi, MD, Richard Baillot, MD, Pierre Voisine,

Michele Gallo, MD, Gino Gerosa, MD

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Aortic valve repair by cusp extension for rheumatic aortic insufficiency in children: Long- term results and impact of extension material Patrick O. Myers,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy

In search of the smoking gun in calcific aortic valve disease

Replicating the success of mitral valve repair in the aortic valve

Bradley G. Leshnower, MD, Robert A. Guyton, MD, Richard J

Thirty-year experience with a bileaflet mechanical valve prosthesis

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Biomaterials for heart valve replacement: Conjectures and refutations

Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD

Hans-Joachim Schäfers, MD

Concomitant replacement of the ascending aorta is free—for some

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Quality of life after aortic valve surgery: Replacement versus reconstruction Diana Aicher, MD, Annika Holz, Susanne Feldner, MD, Volker Köllner, MD,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

The continuing challenge of congenital heart disease in China

Commentary: When a choice is not an echo

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

Racing to the Rubicon Michael J. Reardon, MD, Vinod H. Thourani, MD

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Clinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years John B. Chambers, MD, FRCP,

Francesco Nappi, MD, Cristiano Spadaccio, MD, PhD

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Thanos Sioris, MD, Tirone E

Lessons learned from Melody valve retrieved at transplantation

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results of a 10-year surgical experience Konstantinos Pechlivanidis, MD, Francesco Onorati, MD, PhD, Giuseppe Petrilli, MD, Francesco Santini, MD, Aldo Milano, MD, Salvatore Torre, MD, Daniele Calzaferri, MD, Alessandro Mazzucco, MD, Giuseppe Faggian, MD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 2, Pages 500-508.e1 (August 2014) DOI: 10.1016/j.jtcvs.2013.09.031 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Ten-year actuarial freedom from (A) acute heart failure, (B) reoperations, (C) stroke, and (D) thromboembolisms. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 500-508.e1DOI: (10.1016/j.jtcvs.2013.09.031) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Ten-year actuarial freedom from (A) acute heart failure, (B) reoperations, (C) stroke, and (D) thromboembolisms in New York Heart Association class IV patients. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 500-508.e1DOI: (10.1016/j.jtcvs.2013.09.031) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Ten-year actuarial freedom from (A) acute heart failure, (B) reoperations, (C) stroke, and (D) thromboembolisms in urgent/emergent procedures. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 500-508.e1DOI: (10.1016/j.jtcvs.2013.09.031) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Ten-year actuarial freedom from (A) acute heart failure, (B) reoperations, (C) stroke, and (D) thromboembolisms in endocarditis. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 500-508.e1DOI: (10.1016/j.jtcvs.2013.09.031) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions